Navigation Links
VIDA Diagnostics Introduces Apollo™
Date:11/2/2010

VANCOUVER, British Columbia, Nov. 2, 2010 /PRNewswire/ -- VIDA Diagnostics, Inc., a leader in quantitative pulmonary image analysis, announces the introduction of its Apollo™ Pulmonary Evaluation Software, a comprehensive quantitative software solution for the analysis of major lung diseases, including COPD, asthma, and lung cancer, at the Chest 2010 meeting in Vancouver, BC.  

Apollo strengthens VIDA's leading quantitative pulmonary solution for lung airway and parenchymal analysis and transforms its use into a high volume, time constrained clinical and clinical trial environment.  Apollo, VIDA's first Microsoft release, has significant algorithmic, workflow and dataflow improvements applicable to clinical pulmonary disease analysis.

"We are excited to introduce our Apollo Pulmonary Evaluation Software as a transformative product for VIDA," says Susan A. Wood, Ph.D., President and CEO of VIDA Diagnostics, Inc. "Apollo advances our quantitative approach to pulmonary disease analysis by incorporating the lessons learned from our quantitative imaging experience through academic and clinical trials, and combines it with productivity and connectivity enhancements essential to its widespread clinical use."

Apollo is currently being clinically evaluated at the University of Wisconsin, and the Iowa Comprehensive Lung Imaging Center (iCLIC) at the University of Iowa where it will be used in ongoing trials to validate image-based COPD and asthma measurements.

"An evidence-based approach at the point of care will become increasingly important to the pulmonary physician in evaluating the extent and change of pulmonary disease," states J. Scott Ferguson, MD, Associate Professor, Pulmonology and Critical Care Medicine, Director of Interventional Pulmonology, University of Wisconsin, Madison. "With Apollo, performing interventions with image-guided procedures by the practicing pulmonologist is now achievable and has great potential to improve patient outcomes."

VIDA Diagnostics is currently exhibiting at Chest 2010 Annual Meeting in Vancouver, BC Booth # 1111.

About VIDA Diagnostics, Inc.

VIDA Diagnostics is a leader in quantitative pulmonary image analysis for the diagnosis and treatment of pulmonary diseases. VIDA Diagnostics develops and commercializes pulmonary applications, establishing quantitative pulmonary imaging in routine clinical practice.  VIDA is an established leader in quantitative lung analysis for COPD, emphysema and asthma, establishing objective, quantitative measures for diagnosis, interventional therapies and therapeutic response assessment.

Participating in the emerging pulmonary device market that is expected to grow to nearly $3.8 billion by 2011, VIDA's vision is to establish lung quantitative CT methods as the standard of care for diagnosis and staging of chronic lung disease. VIDA was founded by four University of Iowa faculty members, Eric Hoffman, Ph.D., Geoffrey McLennan, M.D., Ph.D., Joseph Reinhardt, Ph.D. and, Milan Sonka, Ph.D.  For more information on VIDA Diagnostics, visit: www.vidadiagnostics.com.


'/>"/>
SOURCE VIDA Diagnostics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. AdvaMed 2010 Sets New Attendance Record: More than 1,700 Device and Diagnostics Leaders from Across the Country and Around the World Came to Washington, D.C.
2. Quest Diagnostics Reports Third Quarter 2010 Financial Results; Updates Guidance for 2010
3. Reportlinker Adds Imaging Diagnostics Market in Poland 2010 - Development Forecasts for 2010-2012
4. Reportlinker Adds Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics, 4th edition
5. Reportlinker Adds Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 4th Edition
6. AT&T and eCardio Diagnostics Team Up to Advance Cardiac Care Through Innovative Mobile Technology
7. Quest Diagnostics and HP Simplify Electronic Health Records for Physician Practices
8. Quest Diagnostics to Release Third Quarter 2010 Financial Results
9. Reportlinker Adds Global In Vitro Diagnostics (IVD) Market Report: 2010 Edition
10. Roche Diagnostics Supports Fight Against MRSA as a Sponsor of Annual World MRSA Day
11. Siemens Healthcare Diagnostics Publishes Global Trade Item Numbers (GTINs) for its Entire U.S. Product Line to the GHX Health ConneXion(SM) Data Pool
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Issue 52" report to their offering. ... treatment creates a favourable commercial environment for MedImmune to enter. ... base that will serve to drive considerable growth for effective ... serve to cap sales considerably, but development is still in ...
(Date:6/23/2016)... , , , WHEN: ... , , , , LOCATION: , , , Online, with ... , EXPERT PANELISTS:  , , , Frost & Sullivan,s Global Vice ... Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager , ... industry is witnessing an exceptional era. Several new demand spaces, such ...
(Date:6/23/2016)... Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new ... affiliate in Latin America . ... ... ... ...
Breaking Medicine Technology:
(Date:6/25/2016)... , ... June 25, 2016 , ... Austin residents seeking ... American College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical ... effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as ... City area —Johnson is one of the first doctors to perform the treatment. ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited ... To Recovery® program to drive cancer patients to and from their cancer treatments. ... highest quality of life and ongoing independence. Getting to and from medical treatments ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... client, The Grove Investment Group (TGIG), has initiated cultivation and processing operations at ... Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete ...
Breaking Medicine News(10 mins):